These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 29895130

  • 21. DNA repair gene XRCC3 Thr241Met polymorphism and hepatocellular carcinoma risk.
    Duan C, Zhang W, Lu J, Wu H, Liu M, Zhu W.
    Tumour Biol; 2013 Oct; 34(5):2827-34. PubMed ID: 23824570
    [Abstract] [Full Text] [Related]

  • 22. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
    Ji X, Zhang Q, Li B, Du Y, Yin J, Liu W, Zhang H, Cao G.
    Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
    [Abstract] [Full Text] [Related]

  • 23. Association of intercellular adhesion molecule-1 single nucleotide polymorphisms with hepatocellular carcinoma susceptibility and clinicopathologic development.
    Chen TP, Lee HL, Huang YH, Hsieh MJ, Chiang WL, Kuo WH, Chou MC, Yang SF, Yeh CB.
    Tumour Biol; 2016 Feb; 37(2):2067-74. PubMed ID: 26341495
    [Abstract] [Full Text] [Related]

  • 24. DNA repair gene XRCC3 variants are associated with susceptibility to glioma in a Chinese population.
    Huang JY, Yang JF, Qu Q, Qu J, Liu F, Liu FE, Xiong T, Lu SH.
    Genet Mol Res; 2015 Sep 08; 14(3):10569-75. PubMed ID: 26400288
    [Abstract] [Full Text] [Related]

  • 25. Haplotype Based Analysis of XRCC3 Gene Polymorphisms in Thyroid Cancer.
    Sarwar R, Mahjabeen I, Bashir K, Saeed S, Kayani MA.
    Cell Physiol Biochem; 2017 Sep 08; 42(1):22-33. PubMed ID: 28490032
    [Abstract] [Full Text] [Related]

  • 26. Significance of genetic variants in DLC1 and their association with hepatocellular carcinoma.
    Xie CR, Sun HG, Sun Y, Zhao WX, Zhang S, Wang XM, Yin ZY.
    Mol Med Rep; 2015 Sep 08; 12(3):4203-4209. PubMed ID: 26095787
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. The role of ERCC1 and AFP gene polymorphism in hepatocellular carcinoma.
    Huang YL, Wu JR, Fang M, Zhao HL, Liu ZM, Ye J, Huang LS, Zhu B.
    Medicine (Baltimore); 2019 Apr 08; 98(14):e15090. PubMed ID: 30946366
    [Abstract] [Full Text] [Related]

  • 29. Genetic polymorphisms in the Wnt/β-catenin pathway genes as predictors of tumor development and survival in patients with hepatitis B virus-associated hepatocellular carcinoma.
    Kim SS, Cho HJ, Lee HY, Park JH, Noh CK, Shin SJ, Lee KM, Yoo BM, Lee KJ, Cho SW, Cheong JY.
    Clin Biochem; 2016 Jul 08; 49(10-11):792-801. PubMed ID: 26968103
    [Abstract] [Full Text] [Related]

  • 30. A functional polymorphism in PER3 gene is associated with prognosis in hepatocellular carcinoma.
    Zhao B, Lu J, Yin J, Liu H, Guo X, Yang Y, Ge N, Zhu Y, Zhang H, Xing J.
    Liver Int; 2012 Oct 08; 32(9):1451-9. PubMed ID: 22809120
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. miR-492G>C polymorphism (rs2289030) is associated with overall survival of hepatocellular carcinoma patients.
    Yu G, Xiao Q, Ma XP, Chen X, Shi Z, Zhang LY, Chen H, Zhang P, Ding DL, Huang HX, Saiyin H, Chen TY, Lu PX, Wang NJ, Yu H, Sun J, Conran C, Zheng SL, Xu J, Yu L, Jiang DK.
    Tumour Biol; 2016 Jul 08; 37(7):8961-72. PubMed ID: 26753964
    [Abstract] [Full Text] [Related]

  • 33. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL, Sun J, Lai JJ, Jiang Y, Bai LH, Zhang LD.
    World J Gastroenterol; 2015 Jun 07; 21(21):6649-59. PubMed ID: 26074703
    [Abstract] [Full Text] [Related]

  • 34. Secreted protein acidic and rich in cysteine gene variants: Impact on susceptibility and survival of hepatocellular carcinoma patients.
    Darweesh SK, Abd Alziz RA, Omar H, Sabry D, Fathy W.
    J Gastroenterol Hepatol; 2019 Aug 07; 34(8):1424-1431. PubMed ID: 30422339
    [Abstract] [Full Text] [Related]

  • 35. Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma.
    Cai L, Cai X.
    Diagn Pathol; 2014 Dec 31; 9():1000. PubMed ID: 25552204
    [Abstract] [Full Text] [Related]

  • 36. Significant association between XRCC3 C241T polymorphism and increased risk of hepatocellular carcinoma: a meta-analysis.
    Wu D, Jiang H, Yu H, Xu D, Liang J, Jin J.
    Tumour Biol; 2013 Dec 31; 34(6):3865-9. PubMed ID: 23873110
    [Abstract] [Full Text] [Related]

  • 37. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
    Wang G, Chen JH, Qiang Y, Wang DZ, Chen Z.
    World J Gastroenterol; 2015 Apr 07; 21(13):3983-93. PubMed ID: 25852285
    [Abstract] [Full Text] [Related]

  • 38. Association between EGFR polymorphisms and the risk of lung cancer.
    Liu C, Xu X, Zhou Y.
    Int J Clin Exp Pathol; 2015 Apr 07; 8(11):15245-9. PubMed ID: 26823874
    [Abstract] [Full Text] [Related]

  • 39. Contribution of DNA Double-strand Break Repair Gene XRCC3 Genotypes to Triple-negative Breast Cancer Risk.
    Su CH, Chang WS, Hu PS, Hsiao CL, Ji HX, Liao CH, Yueh TC, Chuang CL, Tsai CW, Hsu CM, Lane HY, Bau DT.
    Cancer Genomics Proteomics; 2015 Apr 07; 12(6):359-67. PubMed ID: 26543082
    [Abstract] [Full Text] [Related]

  • 40. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
    Shi XM, Teng F.
    Int J Clin Exp Pathol; 2015 Apr 07; 8(4):4008-14. PubMed ID: 26097588
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.